FROM 24TH JANUARY.
negotiations brought forward with new tier 1 partners New immunoassay technology platform to accelerate PromarkerD rollout in US Clinical samples for first phase of CDx collaborative study received from Janssen Research & Development, LLC Key Opinion Leader (KOL) engagement to drive US demand for PromarkerD
FROM 24TH JANUARY.negotiations brought forward with new tier 1...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.050(4.67%) |
Mkt cap ! $133.6M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.12 | $1.02 | $401.2K | 373.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1130 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 8870 | 1 |
View Market Depth
| Last trade - 15.45pm 11/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |